Doctor Says Living To 120 By End Of Decade Is Possible — What's the Secret?

Even though U.S. life expectancy has declined to 76.4 years, the shortest it's been in nearly two decades, there's hope it will begin to climb in the years to come. One doctor believes extending human life to 120 years is possible by 2030. And if that's not intriguing enough, he believes that number could push closer to 150 by 2050. 

In a groundbreaking revelation that’s stirring both intrigue and skepticism, Dr. Ernst von Schwarz, a noted heart transplant cardiologist with celebrity patients, has shared insights into the burgeoning use of stem cell injections among Hollywood’s elite. 

Don’t Miss:

• The Global Oncology Drugs Market is projected to reach $484.32 billion by 2030. Research Starpax Biopharma’s revolutionary approach to solid tumor treatment.
• Be part of a ground-breaking journey to transform cancer treatment. Discover how a startup’s innovative approach aims to revolutionize the way we fight solid tumors.

Dr. Schwarz’s discussions with Fox News Digital unveiled that these injections not only promise to extend lifespan — potentially to 150 years by mid-century — but also to create a youthfully radiant appearance, reducing perceived age by a decade in some instances. 

His assertions emphasize that aging, while a natural process, is the prime risk factor for a slew of degenerative diseases, which modern regenerative medicine seeks to combat by moving away from reactive treatments toward repairing and regenerating tissue damage.

While this may sound far-fetched to some, many pharmaceutical companies are making major strides in the treatment of diseases with high fatality rates. 

For example, ​​Starpax Biopharma Inc. integrates biochemistry, microbiology, electromagnetism engineering and artificial intelligence (AI) to create Magnetodrones, a targeted cancer treatment platform that delivers drugs directly to tumors using controlled magnetic fields. These Magnetodrones offer a three-pronged therapy approach — localized chemotherapy, hypoxia therapy and systemic immunotherapy — aiming to treat cancer with minimal side effects.

Trending: Until 2016 it was illegal for retail investors to invest in high-growth startups. Thanks to changes in federal law, this Kevin O’Leary-backed startup lets you become a venture capitalist with $100.

Advancements like these are massively important to patients with cancer, while also providing people with a way to invest in the future of healthcare, like Starpax.

Schwarz, who has dedicated over two decades to stem cell research, clarified that no disease has been fully cured by stem cells, but improvements in symptoms and life quality have been evident. This aligns with his broader vision for medicine, where the focus is on prolonging an active and healthy life, not merely extending years of existence. Despite the lack of Food and Drug Administration approval for stem cell use beyond certain cancers, Schwarz has observed tangible benefits in his practice.

Celebrities often seek stem cell therapy before major events, reaping the aesthetic benefits of enhanced skin fullness and a vibrant glow, attributed to stem cells’ role in collagen reconstruction and skin repair. Schwarz’s experience with patients shows that these treatments, which can cost thousands and require repetition every year or so, may stimulate the body’s stem cell production, thus amplifying their regenerative effects.

Beyond aesthetic enhancement, Schwarz has also noted stem cell therapy’s efficacy in treating sexual dysfunction in men, with effects lasting up to a year following a single injection. Burn victims and those with significant skin damage have also seen promising results from these treatments.

Schwarz advises caution, warning against the unregulated market and the all-too-common misleading online information. He stresses the importance of consulting experienced doctors and understanding the source and handling of the stem cells used in treatments.

As he contemplates the future of medicine, Schwarz’s voice remains a beacon of optimism for stem cell therapy’s potential, even as he calls for more rigorous oversight to navigate this wild West of medical innovation. His stance is not just about pioneering new treatments but about advocating for responsible practices that ensure patient safety and the integrity of medical advancement.